Status | Study |
Recruiting |
Study Name: Early-Stage Polycystic Kidney Disease Biomarkers Repository Study Condition: Polycystic Kidney Disease Date: 2016-10-10 |
Not yet recruiting |
Study Name: A Randomised Feasibility Trial of High Water Intake in Polycystic Kidney Disease Condition: Autosomal Dominant Polycystic Kidney Disease Date: 2016-09-18 Interventions: Dietary Supplement: High water intake |
Recruiting |
Study Name: Safety, Pharmacokinetics, Tolerability and Efficacy of Tolvaptan in Children and Adolescents With ADPKD (Autosomal Dominant Polycystic Kidney Disease) Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD) Date: 2016-09-15 Interventions: Drug: Tolvaptan |
Not yet recruiting |
Study Name: The Safety and Efficacy of Catheter-based Renal Denervation Using the Vessix™ Renal Denervation System in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Patients With Severe Debilitating Pain Condition: Autosomal Dominant Polycystic Kidney Disease Date: 2016-04-08 Interventions: Device: Vessix Renal denervation using radio-ablation |
Recruiting |
Study Name: Use of Low Dose Pioglitazone to Treat Autosomal Dominant Polycystic Kidney Disease Condition: Polycystic Kidney Disease Date: 2015-10-30 Interventions: Drug: Pioglitazone Pioglitazon |
Recruiting |
Study Name: Pilot Study of Niacinamide in Polycystic Kidney Disease (NIAC-PKD2) Condition: Polycystic Kidney Disease Date: 2015-09-21 Interventions: Dietary Supplement: Niacinamide |
Enrolling by invitation |
Study Name: Open-label Trial to Evaluate the Long Term Safety of Titrated Immediate-release Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease Condition: Autosomal Dominant Polycystic Kidney Disease Date: 2014-09-25 Interventions: Drug: Tolvaptan (OPC-41061) Tolvaptan tablets (15 or 30 mg) will be self-administered orally as split-do |
Completed |
Study Name: Uncontrolled, Open Label, Pilot and Feasibility Study of Niacinamide in Polycystic Kidney Disease Condition: Polycystic Kidney Disease Date: 2014-05-14 Interventions: Dietary Supplement: Niacinamide Other Name: Vitamin B3 |
Recruiting |
Study Name: The Efficacy of Everolimus in Reducing Total Native Kidney Volume in Polycystic Kidney Disease Transplanted Recipients Condition: Autosomal Dominant Polycystic Kidney Disease Date: 2014-04-28 Interventions: Drug: Everolimus Change from a |
Recruiting |
Study Name: Triptolide-Containing Formulation as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD) Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD) Date: 2014-04-14 Interventions: Drug: Triptolide-Containing Formulation |